Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Perturbagen Concentration Perturbagen Conc Unit Biological Replicate ID Relative Cell Count Normalized Growth Rate Inhibition Value Nominal Division Rate
ZR75B
HR+
Luminal
ZM-447439
AURK
AURK
0.0064
uM
11939.16
0.9919 0.9903 1.6749
ZR75B
HR+
Luminal
ZM-447439
AURK
AURK
0.032
uM
11939.16
0.9836 0.9804 1.6749
ZR75B
HR+
Luminal
ZM-447439
AURK
AURK
0.16
uM
11939.16
1.0296 1.0352 1.6749
ZR75B
HR+
Luminal
ZM-447439
AURK
AURK
0.8
uM
11939.16
0.6652 0.5680 1.6749
ZR75B
HR+
Luminal
ZM-447439
AURK
AURK
4
uM
11939.16
0.8228 0.7801 1.6749
ZR75B
HR+
Luminal
ZM-447439
AURK
AURK
20
uM
11939.16
0.5361 0.3784 1.6749
ZR75B
HR+
Luminal
ZM-447439
AURK
AURK
100
uM
11939.16
0.6889 0.6011 1.6749